MMP9 and neovascular glaucoma: In neovascular glaucoma due to RVO, the VEGF-VEGFR2 pathway suppresses occludin, causing damage to intercellular tight junctions, and activates MMP-9, resulting in the destruction of the blood–retinal barrier [76].